Ipca Laboratories enters into Technology Transfer Agreement with Omexa Formulary

27 Mar 2024 Evaluate

Ipca Laboratories has entered into a Technology Transfer Agreement with Omexa Formulary for a biosimilar clone, process development and knowledge transfer for the global market. Under this Agreement, Ipca will grant to Omexa a non-exclusive right to research, develop, manufacture and market a anti-cancer biosimilar for global market.

This Agreement shall enable Omexa to develop this anti-cancer biosimilar from early stage of development to clinical trials and subsequent commercial launch. This agreement will also strengthen Omexa's capability of biosimilar development.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.


Ipca Laboratories Share Price

1584.10 -0.15 (-0.01%)
23-Dec-2024 15:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1816.00
Dr. Reddys Lab 1341.60
Cipla 1471.70
Lupin 2168.25
Zydus Lifesciences 972.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.